Vunakizumab, CAS [[1792181-33-9]]

Produktübersicht

• Artikelname: Vunakizumab, CAS [[1792181-33-9]]
• Artikelnummer: MCE-HY-P99335
• Hersteller Artikelnummer: HY-P99335
• Alternativnummer: MCE-HY-P99335-10MG,MCE-HY-P99335-1MG,MCE-HY-P99335-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: Anti-Human IL17A Recombinant Antibody, SHR-1314

Produktbeschreibung

Vunakizumab (Anti-Human IL17A Recombinant Antibody) is a recombinant human IgGkappa monoclonal antibody and an Interleukin-17A (IL-17A) inhibitor. Vunakizumab binds to IL-17A to inhibit downstream cytokines and block inflammatory signaling. Vunakizumab can be used for the research of chronic plaque psoriasis and ankylosing spondylitis[1][2].

Produkteigenschaften

• Molekulargewicht: (146.38 kDa)
• Reinheit: 95.00
• CAS Nummer: [1792181-33-9]
• Target-Kategorie: Interleukin Related

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies